Trials / Unknown
UnknownNCT02413437
A Trial on Contrast-enhanced Ultrasound Versus Conventional Ultrasound Guided Biopsy of Liver Neoplasms
The Multi-center Study of Percutaneous Focal Liver Lesions Biopsy Guided by Contrast-Enhanced Ultrasound
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2,088 (estimated)
- Sponsor
- Peking University Cancer Hospital & Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to estimate the clinical value of contrast-enhanced ultrasound in percutaneous biopsy for liver occupied lesion.
Detailed description
The patients with liver neoplasms who need receive percutaneous biopsy were randomized into contrast-enhanced ultrasound(CEUS) group and conventional ultrasound(US) group.The aims include: 1. Comparison the diagnostic accuracy rate, specificity and sensitivity between CEUS and US group. 2. Comparison the diagnostic accuracy rate specificity and sensitivity between smaller(\<3cm) and larger(≥3cm) nodule group. 3. To explore operating strategy of contrast-enhanced ultrasound guided biopsy. 4. To evaluate economic efficiency of contrast-enhanced ultrasound guided biopsy compared with conventional ultrasound guided biopsy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | CEUS guided biopsy | Biopsy was operated under contrast-enhanced ultrasound-guided. |
| OTHER | US guided biopsy | Biopsy was operated under conventional ultrasound-guided. |
| DEVICE | Ultrasound |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2017-06-01
- Completion
- 2017-12-01
- First posted
- 2015-04-09
- Last updated
- 2017-05-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02413437. Inclusion in this directory is not an endorsement.